文献速递乳房整形与再造创面修复

乳房植入物包膜相关鳞状细胞癌二例及文献复习

Squamous Cell Carcinoma Arising in Breast Implant Capsules.
PubMed 文献 · Ann Plast Surg · 2021-01-01

美国最常见的整形手术之一是使用植入物的乳房增大与再造,每年有小部分植入物被取出。本文报告2例包膜切除标本常规病理评估发现与乳房植入物包膜相关的鳞状细胞癌,并讨论其可能发病机制。两例均为长期植入(>10年),表现为急性单侧乳房红斑和肿胀;文献复习另识别5篇类似报告共6例患者,均表现相似且预后不良,平均诊断年龄60岁,从初始植入到诊断平均25年。

要点

  • 长期乳房植入物(>10年)患者出现急性单侧乳房红斑肿胀需警惕包膜相关鳞状细胞癌。
  • 包膜切除标本应送常规病理评估,术中可见包膜增厚钙化伴肉芽肿及角化碎屑侵入胸壁。
  • 该实体罕见、预后差,慢性炎症/刺激及包膜上皮化可能参与发病。

核心结论

  • 乳房植入物包膜相关鳞状细胞癌罕见,文献复习仅识别5篇类似报告共6例患者,均表现相似且预后不良。
  • 由于病例数少,乳房植入物与鳞状细胞癌之间的真实关联尚不清楚。
  • 推测植入物所致慢性炎症/刺激及包膜上皮化在疾病过程中起重要作用,可能代表「慢性炎症性包膜恶性肿瘤」这一新实体。
  • 提高对该实体的认识可能有助于更早怀疑、诊断和处理。

研究设计与样本

  • 病例报告2例,并对文献进行全面复习,识别5篇类似报告共6例患者。

主要发现

  • 2例患者均有长期植入物(>10年),表现为急性单侧乳房红斑和肿胀。
  • 术中两例包膜均增厚钙化,含广泛肉芽肿和角化碎屑侵入胸壁;广泛检查未发现隐匿原发灶。
  • 一例患者在化疗期间死于肿瘤侵犯继发的恶性胸腔积液;另一例经5周化疗后肿块稳定但随后拒绝进一步手术干预。
  • 文献复习的6例患者临床表现相似且预后不良,平均报告诊断年龄60岁,从初始植入到诊断平均25年。

临床怎么用

  • 对长期乳房植入物患者出现急性单侧乳房红斑和肿胀应提高对包膜相关鳞状细胞癌的怀疑。
  • 包膜切除标本应送常规病理评估以发现潜在的包膜相关恶性肿瘤。

局限性

  • 病例数少(本文2例加文献6例),无法确定乳房植入物与鳞状细胞癌之间的真实关联。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Breast augmentation and reconstruction utilizing implants are among the most common plastic surgery procedures performed in the United States. A small proportion of these implants are removed each year. We report 2 cases where routine pathologic evaluation of capsulectomy specimens revealed squamous cell carcinoma associated with the breast implant capsule and discuss the possible pathogenesis of this unusual entity. Both patients had long-standing implants (>10 years) and presented with acute unilateral breast erythema and swelling. Intraoperatively, the capsules for both cases appeared thickened and calcified, containing extensive granulomatosis and keratinaceous debris invading into the chest wall. Extensive workup failed to find an occult primary. One patient died from a malignant pleural effusion secondary to tumor invasion during chemotherapy, and the second patient obtained stabilization of the mass after 5 weeks of chemotherapy but subsequently declined further surgical intervention. A thorough literature review was performed, and 5 similar reports were identified, involving 6 patients. All patients presented with similar clinical presentations as ours and had poor outcomes. The mean reporting age at diagnosis was 60 years, and the average time from initial implant to diagnosis was 25 years. Due to the small numbers of squamous cell carcinomas associated with breast implant capsules, the true association between the 2 is unknown. It is postulated that chronic inflammation/irritation from the breast implant and epithelialization of the capsule play a significant role in the disease process. This may represent a new entity of "chronic inflammatory capsular malignancies." Increased awareness of this entity may allow for earlier suspicion, diagnosis, and management.

来源:Ann Plast Surg,查看原文。版权归原作者所有。

引用

  1. Goldberg MT, Llaneras J, Willson TD, et al. Squamous Cell Carcinoma Arising in Breast Implant Capsules. Ann Plast Surg. 2021. PMID: 32804719. doi:10.1097/SAP.0000000000002524

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。